The first large and comprehensive study of the genetics of a common lung cancer has found that more than half the tumors from that cancer have mutations that might be treated by new drugs that are already in the pipeline or that could be easily developed.
Cancer study points to tighter pairing of drugs and patients
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.